SEARCH RESULTS FOR: "Tag: SAGE"
loading image
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(1)
ARTICLES/BLOGS
2024(1)
2023(1)
2021(2)
2020(2)
2019(5)
2018(5)
2017(3)
2016(3)
2015(1)
CATEGORIES
Analyst Update(2)
Buzz Stocks(10)
Earnings Preview(1)
Expectational Analysis(1)
Indexes and ETFs(1)
Midday Market Check(2)
Opening View(3)
Quantitative Analysis(2)
Stocks On the Move(1)
Trade Postmortem(1)
Unusual Trading Activity(2)

4/17/2024 3:11 PM
Depending on who you ask, a recession is either right around the corner or the stock market is ready to rattle off a seismic bull run. As always, the answer is likely somewhere in the middle of those ...
8/7/2023 2:32 PM
Sage Therapeutics Inc (NASDAQ:SAGE) is crumbling to record lows today, down 52.2% at $17.25 at last check, earlier hitting a low of $16.69. The U.S. Food & Drug Administration (FDA) approved its drug...
9/15/2021 1:36 PM
SAGE Therapeutics Inc (NYSE:SAGE) is in the spotlight today, after the drugmaker received fast-track designation from the U.S. Food and Drug Administration (FDA) for its potential Huntington's diseas...
6/15/2021 11:07 AM
The shares of Sage Therapeutics Inc (NASDAQ:SAGE) are down 16.5% to trade at $60.85 at last check, following lackluster Phase 3 test results for the biotechnology company's depression drug, Zuranolon...
12/1/2020 11:57 AM
The shares of Sage Therapeutics Inc (NASDAQ:SAGE) are down 1.8% at $72.78 at last check, after Raymond James downgraded the stock to "Market Perform" from "Outperform," following its recent $1.5 bill...